Regulating the sale of cannabis could have significant health, societal and economic benefits for the UK.
Researchers identified 'statistically significant' improvements in symptoms, quality of life and a reduction in opioid use.
Prescribed cannabis was associated with an improvement in symptoms, quality of life and a reduction in opioid use.
The study aims to recruit more than 230 glioblastoma patients at 14 NHS hospitals across the UK.
Experts say allowing GPs to initiate cannabis prescriptions would open up access in the UK.
The government's 'lack of understanding' and ‘predictably poor’ response has been criticised.
Reports include patients being labelled as ‘drug addicts’, refused help and referred to social services after disclosing that they use cannabis medicinally.
Khiron Europe is confident that its efforts in collecting evidence will allow the UK to follow in the footsteps of Germany’s thriving medical cannabis market.
Only a tiny fraction of UK medical cannabis patients are accessing the legal market. Why is that and what do we do about it?
United Patients Alliance (UPA) will relaunch its campaign at Brighton Medical Cannabis Summit in April.